| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/14/2004 | EP1407019A2 Intestinal proteins |
| 04/14/2004 | EP1407017A2 Human tumor necrosis factor receptor |
| 04/14/2004 | EP1407015A2 Compositions and methods relating to breast specific genes and proteins |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1407009A2 Hydrolase enzymes and their use in kinetic resolution |
| 04/14/2004 | EP1406951A1 Keratin-based products and methods for their production |
| 04/14/2004 | EP1406931A2 Modification of human variable domains |
| 04/14/2004 | EP1406929A2 Glycoprotein vi fusion proteins |
| 04/14/2004 | EP1406925A2 Survivin interacting protein tpr1 |
| 04/14/2004 | EP1406923A2 Histidine phosphatase interacting protein with 180kd |
| 04/14/2004 | EP1406916A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1218394A4 Differentially expressed genes associated with her-2/neu overexpression |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP0876493B1 Production of bacillus thuringiensis integrants |
| 04/14/2004 | EP0765392B1 Interleukin-5 specific recombinant antibodies |
| 04/14/2004 | CN1489692A HCV antigen/antibody combination assay |
| 04/14/2004 | CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/14/2004 | CN1488641A Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145698C Synthetic insecticide crystalline protein gene |
| 04/14/2004 | CN1145694C Novel human thrombopoietin mutein |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/13/2004 | US6720408 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal |
| 04/13/2004 | US6720183 Cytoplasmic inhibition of gene expression |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720167 Nucleic acid sequence comprising in order a b. thuringiensis cry promoter; a bacteria stab-si sequence, a ribosome binding site, and a sequence encoding one or both proteins of a b. sphaericus binary toxin. |
| 04/13/2004 | US6720165 Generation of preferential immunoglobulin; obtain glycosylated antibody, deglycosylate, expose to enzymatic splitting, recover immunoglobulin |
| 04/13/2004 | US6719983 VMP-like sequences of pathogenic Borrelia |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | US6719972 Induce antigen specific apoptosis in activated t cells; ligands with monoclonal anti-ctla4 antibody that binds to an epitope of ctla4 |
| 04/13/2004 | US6719971 Method for making humanized antibodies |
| 04/13/2004 | US6719968 For therapy of tendinitis, or other tendon or ligament defect |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2195076C Process for modifying the stability of antibodies |
| 04/08/2004 | WO2004029280A2 Anti-hla assay and methods |
| 04/08/2004 | WO2004029273A1 Production method of iturin a and its homologues |
| 04/08/2004 | WO2004029254A1 Method of producing stable isotope-labeled protein |
| 04/08/2004 | WO2004029242A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 04/08/2004 | WO2004029218A2 Receptors and membrane-associated proteins |
| 04/08/2004 | WO2004029078A1 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby |
| 04/08/2004 | WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/08/2004 | WO2004012658A3 Method and device for protein delivery into cells |
| 04/08/2004 | WO2004006840A3 Three dimensional cell patterned bioploymer scaffolds and method of making the same |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2003100015A3 Polypeptide cleavage process |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003095976A3 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/08/2004 | WO2003095482A3 Novel cyclic peptides and use thereof as anti-microbial agents |
| 04/08/2004 | WO2003091273A3 Protein interaction system for multisubunit complexes |
| 04/08/2004 | WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 04/08/2004 | WO2003064469A3 Regulation of human hematopoietin receptor-like protein |
| 04/08/2004 | WO2003057818A3 Process and apparatus for performing a gas-sparged reaction |
| 04/08/2004 | WO2003053158A9 Malleable protein matrix and uses thereof |
| 04/08/2004 | WO2003042249A8 Peptide purification by means of metal ion affinity chromatography |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | US20040068105 Plant thermogenic genes and proteins |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067879 Effective against fungi such as Candida parapsilosis, Candida albicans, Cryptococcus neoformans, and/or Histoplasma capsulatum |
| 04/08/2004 | US20040067573 Lactobacillus culture for use in reducing gastrointestinal inflammation; antiinflammatory agents |
| 04/08/2004 | US20040067553 Membrane protein for diagnosis and treatment of nervous system, endocrine, metabolic, cancer, inflamatory, respiratory, immune and infectious diseases |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067542 Determining the aetiology of carcinogenesis in a mammal; comparing with normal cell/tissue; detection by immunohistochemistry or blotting techniques; use in diagnosis of prostate, breast and skin cancer |
| 04/08/2004 | US20040067517 Of given amino acid sequence; binds with antibodies to the causative agent; expressed by spirochetes of Borrelia burgdorferi |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040066166 Motor control apparatus having current supply phase correction |
| 04/08/2004 | CA2539622A1 Anti-hla assay and methods |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2403025A1 Enzymes with lipase/acyltransferase activity |
| 04/07/2004 | EP1405914A1 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from flavobacterium heparinum |
| 04/07/2004 | EP1405912A1 Genetically modified ecarin and process for producing the same |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405908A1 Creation of high yield heterologous expression cell lines |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404865A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404851A2 Production of proteins in plants |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404825A2 A WALK-THROUGH TECHNIQUE FOR i IN VITRO /i RECOMBINATION OF POLYNUCLEOTIDE SEQUENCES |
| 04/07/2004 | EP1404813A2 Methods of culturing animal cells and polypeptide production in animal cells |
| 04/07/2004 | EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof |
| 04/07/2004 | EP1404713A1 Novel keratinocyte growth factor-2 analogue in hair follicle |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1124843B1 Low allergenic protein variants |
| 04/07/2004 | EP1015622B1 Practical in vitro sialylation of recombinant glycoproteins |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0587791B1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
| 04/07/2004 | CN1487996A Transgenic transchromosomal rodents for making human antibodies |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487086A Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor |
| 04/07/2004 | CN1144875C OMP 26 antigen of haemophilus influenzae |